Rapamycin formulations for oral administration
US5989591A · kind A · utility
112Cited by
12References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 11, 1998 |
| Grant date | Nov 23, 1999 |
| Priority date | — |
| Expiry date | Mar 11, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides rapamycin solid dosage unit which comprises a core and a sugar overcoat, said sugar overcoat comprising rapamycin, one or more surface modifying agents, one or more sugars, and optionally one or more binders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.